6+ hour, 40+ min ago  (815+ words) QIAGEN's AI Leap: Integrating Biology and Biomedical Workflows'BioBuzz QIAGEN's AI Push and it's Control of the Molecular Data Stack I've been following QIAGEN for many years " two decades to be exact. For a company long known as a leader in…...

17+ hour, 56+ min ago  (929+ words) Artificial intelligence in drug discovery has moved past the hype cycle and into its most critical phase: proof. After nearly a decade of investment, 2026 is shaping up to be an inflection point. The industry is now asking harder questions: The…...

2+ mon, 1+ week ago  (288+ words) As the thousands of BioPharma Executives return from this year's JPM Healthcare Week, one theme eclipsed nearly every conversation: artificial intelligence is here, pervasive, and reshaping every corner of the industry. From discovery biology and translational research to clinical development…...